These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 12575520)

  • 1. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 2. A new era in the European marketplace.
    Wagner M
    Mod Healthc; 1990 Oct; 20(39):26-7, 30-3. PubMed ID: 10170601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 4. [European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].
    Alván G
    Lakartidningen; 2003 Oct; 100(44):3541-2. PubMed ID: 14651017
    [No Abstract]   [Full Text] [Related]  

  • 5. The future belongs to Ireland.
    Higgins S
    Med Device Technol; 2002 Dec; 13(10):41. PubMed ID: 12575531
    [No Abstract]   [Full Text] [Related]  

  • 6. Europe and FDA agree to limited inspections.
    Fox JL
    Nat Biotechnol; 1997 Aug; 15(8):714-5. PubMed ID: 9333519
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
    Persidis A; Persidis A
    Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 9. Global markets await. Upcoming economic transition may provide the opening U.S. healthcare merchants need.
    Dine DD
    Mod Healthc; 1989 Jun; 19(23):20-1, 24, 26-7. PubMed ID: 10318255
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical needs of cystic fibrosis patients and policies for fair co-operation between small and middle-sized companies and patient organizations.
    Schlangen M; Reimann AL
    J Cyst Fibros; 2011 Jun; 10 Suppl 2():S110-3. PubMed ID: 21658630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The industry in Europe: more together than apart.
    Med Device Technol; 2005 Nov; 16(9):32, 34, 36-7. PubMed ID: 16438447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreign Establishment Registration and United States agent requirements.
    Nolte CJ; McNamara-Cullinane M
    Med Device Technol; 2002 Dec; 13(10):32-3. PubMed ID: 12575528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 15. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing adoption and affordability of medical devices in Europe.
    Schreyögg J; Bäumler M; Busse R
    Health Policy; 2009 Oct; 92(2-3):218-24. PubMed ID: 19410326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA user fee and Modernisation Act.
    Donawa M
    Med Device Technol; 2002 Dec; 13(10):27-9. PubMed ID: 12575526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 20. Commercial interest grows in glycan analysis.
    Sheridan C
    Nat Biotechnol; 2007 Feb; 25(2):145-6. PubMed ID: 17287732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.